News

Find News

Filter articles

Showing 2361 to 2370 of 2651 results

Dechert hires life sciences partner in Frankfurt

Germany10-06-2014

Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office.

Ferumoxytol patent extended by USPTO

US09-06-2014

AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended.

Kite Pharma enters into licensing agreement with NIH

US09-06-2014

Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer.

Pharma report calls for “wide debate” in Europe

EU06-06-2014

Pharmaceutical professionals should have a “wide-ranging” debate on how IP can be tailored in the face of “major changes” to the industry, including the possibility of “prolonged exclusivity” for certain medicines, according to a report.

Pfizer and Mylan reach Celebrex agreement

US02-06-2014Legal developments

Pfizer and Mylan have agreed to settle litigation related to arthritis treatment Celebrex (celecoxib), Mylan announced today, June 2.

Turkish company causes row over ‘pharmacist’ trademark

Turkey29-05-2014

A pharmaceutical company in Turkey has run into trouble after attempting to register the Turkish word for ‘pharmacist’ as a trademark.

EPO upholds Copaxone patent

EU28-05-2014

Teva has successfully defended a patent for its multiple sclerosis drug Copaxone (glatiramer acetate) in Europe.

Genentech refused appeal in Herceptin case

UK27-05-2014Legal developments

Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.

Acura ends all Aversion litigation with final Sandoz settlement

US23-05-2014Legal developments

US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone).

Mylan quashes morning-after pill dosage patent

UK22-05-2014Legal developments

Generics (UK) Limited, the UK arm of Mylan, has succeeded in invalidating a patent held by Hungarian pharmaceutical company Richter Gedeon at the English High Court.

Showing 2361 to 2370 of 2651 results

LSIPR